Jason R. Ruth
Corporate Officer/Principal presso 501 ACQU
Profilo
Jason R.
Ruth is currently a Partner at Merck Research Ventures.
He is also the Chief Business Officer at 5:01 Acquisition Corp.
since 2020 and the Chief Scientific Officer at Castleman Disease Collaborative Network since 2014.
Previously, he worked as a Principal at 5AM Venture Management LLC from 2017 to 2022.
Dr. Ruth holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from the University of California, Irvine.
Posizioni attive di Jason R. Ruth
| Società | Posizione | Inizio |
|---|---|---|
| 501 ACQU | Corporate Officer/Principal | 01/09/2020 |
| Castleman Disease Collaborative Network | Direttore Tecnico/Scientifico/R&S | 01/03/2014 |
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research Ventures, a subsidiary of Merck Research Laboratories is a venture capital firm founded in 2000. The firm is headquartered in Boston, Massachusetts. | Investitore di Private Equity | - |
Precedenti posizioni note di Jason R. Ruth
| Società | Posizione | Fine |
|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Analista di Private Equity | 01/01/2020 |
Formazione di Jason R. Ruth
| University of California, Irvine | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance 5:01 Acquisition Corp. is a blank check emerging growth company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 31, 2020 and is headquartered in San Francisco, CA. | Finance |
| Castleman Disease Collaborative Network | |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures, a subsidiary of Merck Research Laboratories is a venture capital firm founded in 2000. The firm is headquartered in Boston, Massachusetts. | Finance |
- Borsa valori
- Insiders
- Jason R. Ruth
